Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam

References

1. Conenello, G. M., Zamarin, D., Perrone, L. A., Tumpey, T. & Palese, P.(2007). A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3, 1414–1421. [Google Scholar]
2. Dinh, P. N., Long, H. T., Tien, N. T., Hien, N. T., Mai, L. T. Q., Phong, L. H., Tuan, L. V., Tan, H. V., Nguyen, N. B. & other authors(2006). Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 12, 1841–1847.[CrossRef] [Google Scholar]
3. Gabriel, G., Dauber, B., Wolff, T., Planz, O., Klenk, H. D. & Stech, J.(2005). The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A 102, 18590–18595.[CrossRef] [Google Scholar]
4. Gao, P., Watanabe, S., Ito, T., Goto, H., Wells, K., McGregor, M., Cooley, A. J. & Kawaoka, Y.(1999). Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol 73, 3184–3189. [Google Scholar]
5. Hatakeyama, S., Sakai-Tagawa, Y., Kiso, M., Goto, H., Kawakami, C., Mitamura, K., Sugaya, N., Suzuki, Y. & Kawaoka, Y.(2005). Enhanced expression of an α2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol 43, 4139–4146.[CrossRef] [Google Scholar]
6. Hatta, M., Gao, P., Halfmann, P. & Kawaoka, Y.(2001). Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840–1842.[CrossRef] [Google Scholar]
7. Hatta, M., Hatta, Y., Kim, J. H., Watanabe, S., Shinya, K., Nguyen, T., Lien, P. S., Le, Q. M. & Kawaoka, Y.(2007). Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog 3, 1374–1379. [Google Scholar]
8. Jackson, D., Hossain, M. J., Hickman, D., Perez, D. R. & Lamb, R. A.(2008). A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105, 4381–4386.[CrossRef] [Google Scholar]
9. Li, Z., Chen, H., Jiao, P., Deng, G., Tian, G., Li, Y., Hoffmann, E., Webster, R. G., Matsuoka, Y. & Yu, K.(2005). Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 79, 12058–12064.[CrossRef] [Google Scholar]
10. Maines, T. R., Lu, X. H., Erb, S. M., Edwards, L., Guarner, J., Greer, P. W., Nguyen, D. C., Szretter, K. J., Chen, L. M. & other authors(2005). Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 79, 11788–11800.[CrossRef] [Google Scholar]
11. Naffakh, N., Massin, P., Escriou, N., Crescenzo-Chaigne, B. & van der Werf, S.(2000). Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. J Gen Virol 81, 1283–1291. [Google Scholar]
12. OIE(2010). Update on highly pathogenic avian influenza in animals (type H5 and H7). Accessed 1 March 2010. http://www.oie.int/downld/AVIAN%20INFLUENZA/A_AI-Asia.htm.
13. Ozawa, M., Fujii, K., Muramoto, Y., Yamada, S., Yamayoshi, S., Takada, A., Goto, H., Horimoto, T. & Kawaoka, Y.(2007). Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol 81, 30–41.[CrossRef] [Google Scholar]
14. Reed, L. J. & Muench, H.(1938). A simple method of estimating fifty per cent endpoints. Am J Hyg 27, 493–497. [Google Scholar]
15. Seo, S. H., Hoffmann, E. & Webster, R. G.(2002). Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8, 950–954.[CrossRef] [Google Scholar]
16. Subbarao, E. K., London, W. & Murphy, B. R.(1993). A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67, 1761–1764. [Google Scholar]
17. Wan, X. F., Nguyen, T., Davis, C. T., Smith, C. B., Zhao, Z. M., Carrel, M., Inui, K., Do, H. T., Mai, D. T. & other authors(2008). Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One 3, e3462.[CrossRef] [Google Scholar]
18. WHO(2008). Towards a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 14, e1. [Google Scholar]
19. WHO(2010a). Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines. Accessed 1 March 2010. http://www.who.int/csr/disease/avian_influenza/guidelines/h5n1virus/en/index.html.
20. WHO(2010b). Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. Accessed 11 June 2010. http://www.who.int/csr/disease/avian_influenza/country/cases_table_2010_06_08/en/index.html.